Natalia Główka, Jakub Malik, Tomasz Podgórski, Rafał Stemplewski, Janusz Maciaszek, Julia Ciążyńska, Emilia E Zawieja, Agata Chmurzynska, Paulina M Nowaczyk, Krzysztof Durkalec-Michalski
Journal: Journal of the International Society of Sports Nutrition 2024;21(1):2301384
PMID: 38226646
Caffeine (CAF) is a substance with a long history of performance-enhancing usage. In terms of the impact of CAF in sport, it is noteworthy that its potential may be linked to the specificity of the efforts performed. In this respect, particular attention is drawn to CrossFit/High-Intensity Functional Training (HIFT), which incorporates functional, multi-modal movements, which are performed at high intensity and may improve general physical fitness. This study aimed to assess the acute effects of three different doses of caffeine (3, 6, and 9 mg/kg body mass) compared to a placebo on performance, reaction time, postural stability, heart rate, and perceived exertion in moderately trained CrossFit practitioners. This study was a randomised, double-blind, placebo-controlled crossover trial. The study involved 26 moderately trained CrossFit athletes who participated in five separate testing sessions. Each session included pre-exercise supplementation with one of the three caffeine doses or a placebo. Results showed that supplementation with 6 mg/kg body mass of caffeine showed clinically noticeable improvements in Fight Gone Bad test (FGB) [type of workout] total results, reaction time, and pre-exercise motor time. However, no significant differences were observed between any caffeine dose and placebo in terms of heart rate, perceived exertion, postural stability and reaction time. Whereas, in terms of biochemical markers, lactate concentrations were higher before and after exercise in all caffeine doses compared to placebo. Authors concluded that their findings do not confirm dose-dependent effect of CAF supplementation in moderately trained CrossFit/HIFT participants.
BACKGROUND
Caffeine (CAF) ingestion improves performance in a broad range of exercise tasks. Nevertheless, the CAF-induced, dose-dependent effect on discipline-specific performance and cognitive functions in CrossFit/High-Intensity Functional Training (HIFT) has not been sufficiently investigated. The aim of this study was to evaluate the effect of acute supplementation of three different doses of CAF and placebo (PLA) on specific performance, reaction time (R), postural stability (P), heart rate (HR) and perceived exertion (RPE).
METHODS
In a randomized double-blind placebo-controlled crossover design, acute pre-exercise supplementation with CAF (3, 6, or 9 mg/kg body mass (BM)) and PLA in 26 moderately trained CrossFit practitioners was examined. The study protocol involved five separate testing sessions using the Fight Gone Bad test (FGB) as the exercise performance evaluation and biochemical analyses, HR and RPE monitoring, as well as the assessment of R and P, with regard to (rs762551) and (rs5751876) single nucleotide polymorphism (SNP).
RESULTS
Supplementation of 6 mg/kg induced clinically noticeable improvements in FGB results, R and pre-exercise motor time. Nevertheless, there were no significant differences between any CAF doses and PLA in FGB, HR, HR, RPE, pre/post-exercise R, P variables or pyruvate concentrations. Lactate concentration was higher ( < 0.05) before and after exercise in all CAF doses than in PLA. There was no effect of CYP1A2 or ADORA2A SNPs on performance.
CONCLUSIONS
The dose-dependent effect of CAF supplementation appears to be limited to statistically nonsignificant but clinically considered changes on specific performance, R, P, RPE or HR. However, regarding practical CAF-induced performance implications in CrossFit/HIFT, 6 mg/kg may be supposed as the most rational supplementation strategy.
Full Text Sources:
Medical:
Miscellaneous:
Research Materials:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.